Hideto Kameda

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

Yoshiya Tanaka, Tsutomu Takeuchi, Tsuneyo Mimori et al. · Annals of the Rheumatic Diseases · 2010 · 280 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Keishi Kubo, Arata Azuma, Minoru Kanazawa et al. · Respiratory Investigation · 2013 · 279 citations · Full text

Medicine, Internal Medicine, Pharmacology +17

Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

Hideto Kameda, Hayato Nagasawa, Hiroe Ogawa et al. · PubMed · 2005 · 230 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Yuko Kaneko, Hideto Kameda, Kei Ikeda et al. · Annals of the Rheumatic Diseases · 2018 · 188 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study

Atul Deodhar, Ricardo Blanco, Eva Dokoupilová et al. · Arthritis & Rheumatology · 2020 · 160 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Medicine +15